During the interaction between antigen-presenting cells and T cells, CTLA-4, which functioned as a negative T-cell activation modulator in lymphoid tissues, is up-regulated on T cells due to the binding of tumor antigens to T-cell receptors. Here, CTLA4 is linked to neoplasm.